Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
Study NCT ID:
NCT04324112
Status:
RECRUITING
Last Update Posted:
2025-11-10
First Post:
2020-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2028-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-26
First Submit QC Date:
None
Study First Post Date:
2020-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-07
Last Update Post Date:
2025-11-10
Last Update Post Date Type:
ESTIMATED